Neural Therapeutics, Inc. (NURL.CX)

0.015 0.00 (0.00%) CAD  |  CNSX  |  Feb 23, 16:00
More

Neural Therapeutics Average Diluted Shares Outstanding (Quarterly)

Average Diluted Shares Outstanding (Quarterly) Chart

View Average Diluted Shares Outstanding (Quarterly) for NURL.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years

View Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Quarterly) Benchmarks

View Average Diluted Shares Outstanding (Quarterly) Benchmarks
Start Trial
BioMark Diagnostics, Inc. Upgrade
Justera Health Ltd. Upgrade
Wesana Health Holdings, Inc. --
Arch Biopartners, Inc. Upgrade
Biocure Technology, Inc. Upgrade